Trial reportDepression and anxiety2026
Effects of High-Frequency rTMS Combined With Physical Exercise on Mood Disorders in Patients With Methamphetamine Use Disorder: A Randomized Clinical Trial.
Trial report in Depression and anxiety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effects of High-Frequency rTMS Combined With Physical Exercise on Mood Disorders in Patients With Methamphetamine Use Disorder: A Randomized Clinical Trial.Depression and anxiety · 2026Trial
- Predictive roles of serum IL-33/ST2 and BDNF in depressed patients with repetitive transcranial magnetic stimulation: a pilot study.Frontiers in human neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mood disorders are a severe symptom in patients with methamphetamine (MA) use disorder (MUD) during withdrawal and are closely associated with the risk of relapse. While both standalone repetitive transcranial magnetic stimulation (rTMS) and physical exercise (PE) have shown positive effects on regulating mood disorders, the potential synergistic benefits of their combined use remain unclear. This study aims to investigate the effects of high-frequency rTMS (10 Hz) combined with PE on mood disorders in patients with MUD and to identify the relevant factors associated with emotional regulation. Methods: Using a randomized clinical trial design, 54 male patients with MUD were randomly assigned to a PE group, an rTMS combined with PE (rTMS + PE) group, and a control group (CG). All groups received interventions three times per week for a total of 12 weeks (8 weeks of intervention + 4 weeks of follow-up). The PE group received 10-min of health education and 35-min of exercise intervention, the rTMS + PE group received 10-min of 10 Hz rTMS administered over the left dorsolateral prefrontal cortex (DLPFC) and 35-min of exercise intervention, and the CG only received 45 min of health education. Measurements for depression, anxiety, MA craving, and blood neurotransmitters were taken from participants at baseline, the 8th week, and the follow-up period. Results: (1) Compared with the CG, both intervention groups showed significant reductions in depression, anxiety, and MA craving after the 8-week intervention, and these improvements were accompanied by marked increases in the blood levels of dopamine (DA), β-EP, and 5-HT. Furthermore, these effects persisted for up to 1 month after the intervention concluded. (2) Compared to the PE group, the rTMS + PE group demonstrated significantly lower craving and higher DA levels at the 8th week, with the latter exhibiting superior sustained intervention effects during the follow-up period (such as negative emotions, craving, DA, and β-EP). (3) The reduction of negative emotions is not only related to the intervention increasing the release level of neurotransmitters in the blood but also to the decrease in MA craving. Conclusion: These findings indicate that adding high-frequency rTMS to moderate-intensity exercise can produce better therapeutic effects (such as emotion regulation and craving reduction) and increase the sustained impact on the rehabilitation of patients with MUD during the withdrawal period, thus providing a novel strategy for treatment of MUD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.